446 related articles for article (PubMed ID: 11867523)
21. Role of EBERs in the pathogenesis of EBV infection.
Iwakiri D; Takada K
Adv Cancer Res; 2010; 107():119-36. PubMed ID: 20399962
[TBL] [Abstract][Full Text] [Related]
22. EBNA promoter usage in EBV-negative Burkitt lymphoma cell lines converted with a neomycin-resistant EBV strain.
Maeda A; Kiss C; Chen F; Ehlin-Henriksson B; Nagy N; Szekely L; Takada K; Klein E; Klein G
Int J Cancer; 2001 Sep; 93(5):714-9. PubMed ID: 11477584
[TBL] [Abstract][Full Text] [Related]
23. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
Perez-Chacon G; de Los Rios C; Zapata JM
Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
[TBL] [Abstract][Full Text] [Related]
24. Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells.
Hong M; Murai Y; Kutsuna T; Takahashi H; Nomoto K; Cheng CM; Ishizawa S; Zhao QL; Ogawa R; Harmon BV; Tsuneyama K; Takano Y
J Cancer Res Clin Oncol; 2006 Jan; 132(1):1-8. PubMed ID: 16180023
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis.
Ruf IK; Rhyne PW; Yang C; Cleveland JL; Sample JT
J Virol; 2000 Nov; 74(21):10223-8. PubMed ID: 11024153
[TBL] [Abstract][Full Text] [Related]
26. Role of bcl-2 in Epstein-Barr virus-induced malignant conversion of Burkitt's lymphoma cell line Akata.
Komano J; Takada K
J Virol; 2001 Feb; 75(3):1561-4. PubMed ID: 11152530
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic features and Epstein-Barr virus infection status of Burkitt's lymphoma in Guangzhou district.
Huang YH; Wu QL; Zong YS; Feng YF; Liang JZ; Hou JH; Shao Q; Fu J
Ai Zheng; 2009 Aug; 28(8):805-12. PubMed ID: 19664325
[TBL] [Abstract][Full Text] [Related]
28. Association between Epstein-Barr virus and Burkitt's lymphoma in Taiwan.
Chao TY; Wang TY; Lee WH
Cancer; 1997 Jul; 80(1):121-8. PubMed ID: 9210717
[TBL] [Abstract][Full Text] [Related]
29. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
[TBL] [Abstract][Full Text] [Related]
30. Stable expression of EBERs in immortalized nasopharyngeal epithelial cells confers resistance to apoptotic stress.
Wong HL; Wang X; Chang RC; Jin DY; Feng H; Wang Q; Lo KW; Huang DP; Yuen PW; Takada K; Wong YC; Tsao SW
Mol Carcinog; 2005 Oct; 44(2):92-101. PubMed ID: 16086371
[TBL] [Abstract][Full Text] [Related]
31. The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF-3.
Kanda K; Decker T; Aman P; Wahlström M; von Gabain A; Kallin B
Mol Cell Biol; 1992 Nov; 12(11):4930-6. PubMed ID: 1406670
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus gene expression in interferon-treated cells. Implications for the regulation of protein synthesis and the antiviral state.
Clarke PA; Sharp NA; Arrand JR; Clemens MJ
Biochim Biophys Acta; 1990 Aug; 1050(1-3):167-73. PubMed ID: 2169891
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas.
Kennedy G; Komano J; Sugden B
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14269-74. PubMed ID: 14603034
[TBL] [Abstract][Full Text] [Related]
34. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma.
Yoshizaki T; Endo K; Ren Q; Wakisaka N; Murono S; Kondo S; Sato H; Furukawa M
Auris Nasus Larynx; 2007 Mar; 34(1):73-8. PubMed ID: 17129696
[TBL] [Abstract][Full Text] [Related]
35. Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells.
Renouf B; Hollville E; Pujals A; Tétaud C; Garibal J; Wiels J
Leukemia; 2009 Sep; 23(9):1557-63. PubMed ID: 19421231
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling.
Samanta M; Iwakiri D; Takada K
Oncogene; 2008 Jul; 27(30):4150-60. PubMed ID: 18362887
[TBL] [Abstract][Full Text] [Related]
37. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines.
Röth A; Pfaff P; Lange W; Finke J
Cytokines Mol Ther; 1996 Mar; 2(1):21-8. PubMed ID: 9384686
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.
Kelly GL; Milner AE; Tierney RJ; Croom-Carter DS; Altmann M; Hammerschmidt W; Bell AI; Rickinson AB
J Virol; 2005 Aug; 79(16):10709-17. PubMed ID: 16051863
[TBL] [Abstract][Full Text] [Related]
39. Expression of genes for the Epstein-Barr virus small RNAs EBER-1 and EBER-2 in Daudi Burkitt's lymphoma cells: effects of interferon treatment.
Clarke PA; Sharp NA; Clemens MJ
J Gen Virol; 1992 Dec; 73 ( Pt 12)():3169-75. PubMed ID: 1335024
[TBL] [Abstract][Full Text] [Related]
40. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
